Trial record 1 of 1 for:
Karyopharm EMN29
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05028348 |
|
Recruitment Status :
Recruiting
First Posted : August 31, 2021
Last Update Posted : February 22, 2023
|
Sponsor:
Stichting European Myeloma Network
Collaborator:
Karyopharm Therapeutics Inc
Information provided by (Responsible Party):
Stichting European Myeloma Network
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2026 |
| Estimated Study Completion Date : | March 2029 |